FAMILIAL HYPERCHOLESTEROLEMIA (FH): TREATMENT AND POTENTIAL CURE? What is Familial Hypercholesterolemia or FH? FH is an autosomal dominant inherited genetic condition that involves approximately 30 million patients across the world. It is underdiagnosed with only 15% of Americans with FH having received the diagnosis. FH is caused by an abnormal variant of one or more […]
ARTS IN HEALTH AND MEDICINE
This article was written in collaboration with Kimberly Kirklin, Director of UAB Arts In Medicine, and Dr Rachel Easterwood, a Hospitalist with Mount Sinai Health System in New York. ARTS IN HEALTH Arts in Health is a diverse, multidisciplinary approach dedicated to improving health through arts. The field integrates visual arts and design, musical, literary, […]
HYPERTENSION, THE SILENT KILLER
This article was written in collaboration with Dr. Suzanne Oparil, M.D. Distinguished Professor of Medicine. Professor of Cell, Developmental and Integrative Biology. Director, Vascular Biology and Hypertension Program. Section Chief of Vascular Biology and Hypertension, at the University of Alabama at Birmingham. HYPERTENSION, THE SILENT KILLER Hypertension is a pervasive problem and affects nearly 50% of […]
THE HDL CHOLESTEROL CONUNDRUM
THE HDL CHOLESTEROL CONUNDRUM The role of High-density lipoprotein (HDL) cholesterol in the development of atherosclerosis and cardiovascular (CV) morbidity and mortality has long been recognized. Epidemiological studies have demonstrated an inverse relationship between HDL cholesterol and CV events. HDL is incorporated in the calculation of the 10-yr ASCVD risk in patients who have never […]
NON-STATIN TREATMENT FOR CHOLESTEROL
This article was written in collaboration with Dr. John J.P. Kastelein, M.D., Ph.D., FESC.Professor of Medicine, University of Amsterdam. NON-STATIN THERAPIES FOR LDL CHOLESTEROL LOWERING The role of statin in the treatment of patients with atherosclerotic cardiovascular disease (ASCVD) has been well demonstrated to lower major cardiovascular events. It is the number one recommendation by […]
LIPOPROTEIN (a), A BIOMARKER FOR STROKE
This article was written in collaboration with Dr. Leslie Cho, MD.Director of the Cleveland Clinic’s Women’s Cardiovascular Center. Lp (a) OR LIPOPROTEIN (a), A BIOMARKER FOR HEART DISEASE AND STROKE Cardiovascular disease remains the leading cause of death and disability worldwide. Despite advances in lipid management, there remain significant risks of heart disease and stroke […]
IN “REGARDS” TO THE STROKE BELT.
This article was written in collaboration with Dr. George Howard, Distinguished Professor in the department of Biostatistics, retired from the UAB School of Public Health.
THE CHRONIC LEAKY MITRAL VALVE
This article was written in collaboration with Dr. Mustafa Ahmed, Associate Professor of Medicine, Director of the Structural and Interventional Cardiology Program at the University of Alabama, at Birmingham. CHRONIC MITRAL INSUFFICIENCY: In this report, we would like to concentrate on the primary mitral insufficiency which is a disease of the mitral valve apparatus (mitral […]
THE CHRONIC LEAKY AORTIC VALVE
This article was written in collaboration with Dr. Mustafa Ahmed, Associate Professor of Medicine, Director of the Structural and Interventional Cardiology Program at the University of Alabama, at Birmingham. CHRONIC AORTIC INSUFFICIENCY: The most common causes of aortic valve insufficiency (aortic regurgitation) in the US are the bicuspid aortic valve and the primary disease of […]
DOPPLER ECHOCARDIOGRAPHY: PAST, PRESENT, AND FUTURE
This article was written in collaboration with Dr. Nelson Schiller, Founder of the UCSF Adult Doppler Echocardiography Laboratory and the Adult Congenital Heart Disease clinic. DOPPLER ECHOCARDIOGRAPHY: Since its development in the 1970s, Doppler echocardiography has occupied a position of increasing importance in the assessment of patients with valvular heart disease. Continuous-wave and pulsed Doppler […]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 9
- Next Page »